https://www.pharmaceutical-technology.com/data-insights/belimumab-gsk-cryoglobulinemia-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-282561&utm_campaign=recommended-articles-pi
Belimumab is under clinical development by GSK and currently in Phase II for Cryoglobulinemia.
belimumabgskcryoglobulinemialikelihoodapproval